The touchless, automated GO Pass kiosk is one of several form factors available.
GO Pass facilitates consistent and easy screening. It has simply taken our COVID-19 protocol to the next level.
LANCASTER, Pa. (PRWEB)
September 16, 2020
Today, Clio Health launched the Clio Health Go app featuring GO Pass to direct students, staff, and visitors to complete a quick, confidential COVID-19 screening and biometric analysis in order to receive an electronic entrance pass. Similar to scanning a boarding pass at an airport kiosk, users scan their electronic GO Pass once they arrive on campus. The results can be read using any smartphone or GO Pass kiosk. No specific symptom data are shared, instead venues receive anonymous, time-stamped images of the results to verify whether or not a user has been cleared for entry. GO Pass is designed to improve outcomes while overcoming the poor performance of contact tracing and isolation. It is based on immunology, science, and data analytics.
The Clio Health Go app is currently available in the App Store and Google Play and in closed pilots with area schools, health systems, medical practices, food processing plants, community and religious organizations. The app is scheduled to roll out nationally this fall. During the pilot phase, you can get access to GO Pass through a Kickstarter campaign. A variety of reward bundles are available to GO Pass backers. The campaign ends in early October.
Steve Lisk, Head of School, at Lancaster Country Day, said, “Staff and students can now complete COVID-19 screening remotely in their homes or car line prior to nearing the building or boarding the bus. This reduces the risk that someone will spread the virus on campus. GO Pass uses encryption to secure identity and medical data, providing an additional layer of privacy to those opposed to facial recognition technologies. GO Pass facilitates consistent and easy screening. It has simply taken our COVID-19 protocol to the next level.”
Mike Simpson, Head of The Stone Independent School, stated: “We pride ourselves on providing students with tools and resources that shape the 21st century. We are thrilled to provide our staff and students with a hands-on 21st century solution for COVID-19 preparedness. Our students get an opportunity to use technologies and AI-assisted insights that not only protect our community at Stone, but ultimately improve and shape the future of health and safety for all.”
“Screening employees was causing huge lines at shift changes and lots of employee frustration. The GO Pass system actually made the process ‘kind of cool’ – it’s fast and it gives our employees confidence in the safety of our workplace,” said Jeff Lehman, President, Shank’s Extracts, LLC.
GO Pass personal information is secured by Powch™, a patent-protected pseudonymity system. It protects identity using cryptography, in a manner similar to Bitcoin and blockchain. In keeping with its mission to further public good, Clio Health will open source COVID-19 risk assessment algorithms used in GO Pass, and will share anonymized data to foster advancements in battling the pandemic.
ABOUT CLIO HEALTH GO AND GO PASS
Clio Health Go is focused on leveraging AI to disrupt healthcare and change the way we manage, understand, and improve our health. It is a subsidiary of Aspire Ventures, LLC.
GO Pass is a product of MedStatix, an Aspire Ventures sister company. GO Pass is powered by Aspire’s adaptive AI platform, A2I, to provide on-demand access to automated health assessments, deeper health insights, and action plans for better health and wellness. GO Pass is the most recently developed feature on the Clio Health Go platform. https://clio.health/
Committed to innovation in healthcare, Aspire Ventures co-founded the Smart Health Innovation Lab (iLab) with Penn Medicine Lancaster General Health and Capital BlueCross in 2017, effectively bringing down the long-standing operational silos in healthcare that have made it difficult to create lasting change. The collaborative work at iLab has resulted in global recognition and continues to fuel innovation.
Contact:
Melissa Sfida-Allen
melissa@aspirevc.com
717-799-9195
Share article on social media or email: